ClinicalTrials.Veeva

Menu

3D Biomimetic Spine Unit Model Through the Integration of Bioprinting and Transcriptomics (CDP-SUBT)

I

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Status

Enrolling

Conditions

Degenrative Disc Disease

Study type

Observational

Funder types

Other

Identifiers

NCT07250126
CDP-SUBT
GR20250006 (Other Identifier)

Details and patient eligibility

About

The general objective of this project is to define the transcriptional profile of primary human cells derived from the nucleus pulposus (NP), annulus fibrosus (AF), and cartilaginous endplate (CEP), and to use this information as a reference to assess the biological relevance of a biomimetic spinal unit model obtained through bioprinting. By developing an in vitro model of human origin that incorporates key components of the spinal unit and applying transcriptional analyses to both native cells and their counterparts recovered from the 3D construct, the study will evaluate how accurately the bioprinted model reproduces the identity and heterogeneity of the native discal environment.

Enrollment

5 estimated patients

Sex

All

Ages

30 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Signature of the Informed Consent for the study
  • Age 30-70 years (included)
  • Pfirrmann grade III-V
  • Need to undergo spinal surgery

Exclusion criteria

  • Presence of HIV, HBC, HCV or TPHA infection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems